|
|
|
|
| LEADER |
04620nmm a2200433 u 4500 |
| 001 |
EB000355782 |
| 003 |
EBX01000000000000000208834 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
130626 ||| eng |
| 020 |
|
|
|a 9780387698052
|
| 100 |
1 |
|
|a Green, Jeffrey E.
|e [editor]
|
| 245 |
0 |
0 |
|a Genetically Engineered Mice for Cancer Research
|h Elektronische Ressource
|b design, analysis, pathways, validation and pre-clinical testing
|c edited by Jeffrey E. Green, Thomas Ried
|
| 250 |
|
|
|a 1st ed. 2012
|
| 260 |
|
|
|a New York, NY
|b Springer New York
|c 2012, 2012
|
| 300 |
|
|
|a XX, 632 p
|b online resource
|
| 505 |
0 |
|
|a Foreword -- Preface -- Overview of Designing Genetically-Engineered Mouse Models -- The Use of Cre-loxP Technology and Inducible Systems to Generate Mouse Models of Cancer -- Using Recombineering Technology To Create Genetically Engineered Mouse Models -- Insertional Mutagenesis for Generating Mouse Models of Cancer -- The RCAS/TVA Somatic Gene Transfer Method In Modeling Human Cancer -- Target-selected ENU Mutagenesis to Develop Cancer Models in the Rat -- The Tumor Pathology of Genetically Engineered Mice: Genomic Pathology -- Genomic DNA Copy Number Alterations in Mouse Cancer Models and Human Cancer -- Characterization of chromosomal translocations in mouse models of hematological malignancies using spectral karyotyping (SKY), FISH, and immunocytochemistry -- Expression Profiling of Mouse Models of Human Cancer: model categorization and guidance for preclinical testing -- Imaging mouse models of human cancer -- Identifying Mammary Epithelial Stem and Progenitor Cells --
|
| 505 |
0 |
|
|a Mouse Models of Human Cancer: Role inPre-clinical Testing and Personalized Medicine -- Mighty, But How Useful? The Emerging Role of Genetically Engineered Mice in Cancer Drug Discovery and Development -- Index.
|
| 505 |
0 |
|
|a Differentiation Programs in Development and Cancer -- Roles of p53 and PRB Tumor Suppressor Networks in Human Cancer: Insight from Studies in the Engineered Mouse -- Mouse Models for Colorectal Cancer -- Src family tyrosine kinases: Implications for mammary tumor progression -- Maspin and Suppression of Tumor Metastasis -- Epigenetic Mouse Models -- Modeling Transforming Growth Factor-ß Signaling in Cancer -- Modeling Stromal-Epithelial Interactions.- Utilizing Mouse Models of Human Cancer for Assessing Immune-Modulation of Cancer Development.- Transplanted Tumor Models For Preclinical Drug Testing And The Potential Benefit Of Genetically Engineered Mouse Models -- The Development and Use of Genetically Tractable Pre-Clinical Mouse Models -- Animal Models for Breast Cancer Prevention Resarch -- Oncogene Addiction: Mouse Models and Clinical Relevance for Molecularly Targeted Therapies -- Mouse Models in Preclinical Drug Development- Applications to CNS Models --
|
| 653 |
|
|
|a Medical Genetics
|
| 653 |
|
|
|a Chemical Biology
|
| 653 |
|
|
|a Medicine / Research
|
| 653 |
|
|
|a Biology / Research
|
| 653 |
|
|
|a Medical genetics
|
| 653 |
|
|
|a Cancer
|
| 653 |
|
|
|a Parasitology
|
| 653 |
|
|
|a Biochemistry
|
| 653 |
|
|
|a Biomedical Research
|
| 653 |
|
|
|a Medical Microbiology
|
| 653 |
|
|
|a Cancer Biology
|
| 653 |
|
|
|a Medical microbiology
|
| 700 |
1 |
|
|a Ried, Thomas
|e [editor]
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b Springer
|a Springer eBooks 2005-
|
| 028 |
5 |
0 |
|a 10.1007/978-0-387-69805-2
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-0-387-69805-2?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 616.994
|
| 082 |
0 |
|
|a 571.978
|
| 520 |
|
|
|a Technological advances in manipulating the mouse genome has led to the development of sophisticated genetically-engineered models of human cancer that recapitulate many molecular, biologic and histologic features of human tumors. This book provides an overview of the design considerations and technical approaches used to generate these important models of human cancer. These models are designed to recapitulate molecular aberrations in target organs known to drive human cancers. State-of-the-art methods to analyze genome and transcriptome alterations in these models and particular relationships to human cancers are presented. Mouse-human comparisons of tumor pathologies are exemplified. Criteria for selecting relevant models for preclinical studies that might be translatable to the treatment of human cancers are discussed. The topics presented in this book will be invaluable to both newcomers to the field as well as established investigators who use genetically-engineered mouse models to study the development, progression and treatment of cancer
|